Infection and Immunity

Total Page:16

File Type:pdf, Size:1020Kb

Infection and Immunity INFECTION AND IMMUNITY Volume 26 Contents for October 1979 Number 1 Bacterial and Mycotic Infections Chemotaxigenesis by Cell Surface Components of Staphylococcus aureus. DAVID J. SCHMELING,* PHILLIP K. PETERSON, DALE E. HAMMERSCHMIDT, YOUNGKI KIM, JAN VERHOEF, BRIAN J. WILKINSON, AND PAUL G. QUIE ... 57 Use of Ganglioside Affinity Filters to Identify Toxigenic Strains of Clostridium botulinum Types C and D. SIDNEY HAYES .150 Effects of Low Concentrations of Zinc on the Growth and Dimorphism of Candida albicans: Evidence for Zinc-Resistant and -Sensitive Pathways for Mycelium Formation. GLENN W. BEDELL AND DAVID R. SOLL* .348 Nature of the Fructan of Streptococcus mutans OMZ 176. ALICE J. CORRIGAN AND JOHN F. ROBYT* 387 Viral Infections Natural Killing of Herpes Simplex Virus Type 1-Infected Target Cells: Normal Human Responses and Influence of Antiviral Antibody. CLARA CHING AND CARLOS LoPEZ* .49 Sites That Bind Polymerized Albumin on Hepatitis B Surface Antigen Particles: Detection by Radioimmunoassay. BENGT G. HANSSON* AND ROBERT H. PURCELL ......... 125 Behavior of Vaccine Revertants of Temperature-Sensitive Mutants of Influenza Virus in Ferret Tracheal Organ Culture. STEVEN R. MOSTOW,* JANET A. HOPKINS, AND PETER F. WRIGHT . 193 Hemagglutinin Mutants of Swine Influenza Virus Differing in Replication Charac- teristics in Their Natural Host. EDWIN D. KILBOURNE,* SANDY MCGREGOR, AND BERNARD C. EASTERDAY ......................................... 197 Surface Markers and Size of Lymphocytes in Human Umbilical Cord Blood Stim- ulated into Deoxyribonucleic Acid Synthesis by Epstein-Barr Virus. J. Ro- BINSON,* A. FRANK, E. HENDERSON, J. SCHWEITZER, AND G. MILLER .225 Baculovirus Replication in a Mosquito (Dipteran) Cell Line. KENNETH E. SHER- MAN * AND ARTHUR H. MCINTOSH .232 Prevalence of Antibody to the Norwalk Virus in Various Counties. HARRY B. GREENBERG,* JOSE VALDESUSO, ALBERT Z. KAPIKIAN, ROBERT M. CHANOCK, RICHARD G. WYATT, WOLF SZUMUNESS, JAMES LARRICK, JONATHAN KAPLAN, ROBERT H. GILMAN, AND DAVID A. SACK .270 Live Victoria/75ts-l[E] Influenza A Virus Vaccines in Adult Volunteers: Role of Hemagglutinin Immunity in Protection Against Illness and Infection Caused by Influenza A Virus. R. GORDON DOUGLAS, JR., LEWIS J. MARKOFF, BRIAN R. MURPHY,* ROBERT M. CHANOCK, ROBERT F. BETTS, FREDERICK G. HAY- DEN, MYRON M. LEVINE, GILLIAN A. VAN BLERK, STEVEN B. SOTMAN, AND DAVID R. NALIN .... 274 Relationship of Genotype of Recombinants of Influenza A/Hong Kong/68-tsl[E] Virus Used as Live Virus Vaccines to Virulence in Humans. LEWIS J. MAR- KOFF, FRANCOISE THIERRY, BRIAN R. MURPHY,* AND ROBERT M. CHANOCK 280 Abortive Replication of Vaccinia Virus in Activated Rabbit Macrophages. NANCY A. BUCHMEIER, SYDNEY R. GEE, FREDERICK A. MURPHY, AND WILLIAM E. RAWLS* .328 Susceptibility of Inbred Mice to Chronic Central Nervous System Infection by Theiler's Murine Encephalomyelitis Virus. HOWARD L. LIPTON* AND MAURO C. DAL CANTO ... ... 369 Continued on following page Continued from precedingpage Oral Microbiology and Immunology Colonization of the Cementum Surface of Teeth by Oral Gram-Negative Bacteria. ROGER A. CELESK, ROBERT M. MCCABE, AND JACK LONDON* ... 15 Effect of Oral Administration of Glucosyltransferase Antigens on Experimental Dental Caries. DANIEL J. SMITH,* MARTIN A. TAUBMAN, AND JEFFREY L. EBERSOLE ............................................................ 82 Fatty Acid Composition of Gliding Bacteria: Oral Isolates of Capnocytophaga Compared with Sporocytophaga. S. C. HOLT,* G. J. FORCIER, AND B. J. TAKACS .. ... ............ 298 Phospholipid Composition of Gliding Bacteria: Oral Isolates of Capnocytophaga Compared with Sporocytophaga. S. C. HOLT,* J. DOUNDOWLAKIS, AND B. J. TAKACS ... 305 Pathogenic Mechanisms, Ecology, and Epidemiology Suppression of Lymphocyte Response to Concanvalin A by Mucopolysaccharide Material from Treponema pallidum-Infected Rabbits. RUSSELL F. BEY,* RUSSELL G. JOHNSON, AND T. J. FITZGERALD ..... 64 Adherence of Mycoplasma pneumoniae to Glass Surfaces. JURGEN FELDNER, WOLFGANG BREDT,* AND SHMUEL RAZIN .. ....... ..... 70 Influence of Encapsulation on Phagocytosis of Pasteurella multocida by Bovine Neutrophils. SAMUEL K. MAHESWARAN* AND ELAINE S. THIES .. 76 Pathogenic Species of the Genus Haemophilus and Streptococcus pneumoniae Produce Immunoglobulin Al Protease. MOGENS KILIAN, JIRI MESTECKY, * AND RALPH E. SCHROHENLOHER .143 Macrophage Dysfunction After Burn Injury. LELAND D. LOOSE* AND JIRI TUR- INSKY ... 157 Isolation and Partial Characterization of Two Different Heat-Stable Enterotoxins Produced by Bovine and Porcine Strains of Enterotoxigenic Escherichia coli. R. A. KAPITANY,* G. W. FORSYTH, A. SCOOT, S. F. MCKENZIE, AND R. W. WORTHINGTON .. 173 Bacterial Adherence to Pharyngeal Cells in Smokers, Nonsmokers, and Chronic Bronchitics. VICTOR FAINSTEIN* AND DANIEL M. MUSHER .178 Effect of Cholera Toxin on the Antiviral and Anticellular Activities of Human Leukocyte Interferon. AKIRA FUSE* AND TSUGUO KUWATA .235 Immunoglobulin Al Protease Production by Haemophilus influenzae and Strep- tococcus pneumoniae. CAROLYN J. MALE ............................... 254 Group B Streptococcal Type Ia Sepsis in Mice After Intranasal Inoculation and the Effect of Infection on Lungs. D. E. WENNERSTROM .. ............ 287 Binding of Lipoteichoic Acid of Group A Streptococci to Isolated Human Eryth- rocyte Membranes. THOMAS H. CHIANG, MICHAEL L. ALKAN, AND EDWIN H. BEACHEY* ... ....... 316 Relationship Between the Intestinal Permeability to Macromolecules and Invasion of Septicemia-Inducing Escherichia coli in Neonatal Piglets. HIDEO MUR- ATA,* HIDEYUKI YAGUCHI, AND SHIGEO NAMIOKA .339 Interaction of Nocardia asteroides at Different Phases of Growth with In Vitro- Maintained Macrophages Obtained from the Lungs of Normal and Immunized Rabbits. B. L. BEAMAN .......... 355 Attachment Pili from Enterotoxigenic Escherichia coli Pathogenic for Humans. CARL F. DENEKE,* GRACE M. THORNE, AND SHERWOOD L. GORBACH .362 Significance of Abnormal Rabbit Ileal Histology in the Pathogenesis of Diarrhea. MARK DONOWITZ,* ALAN N. CHARNEY, RICHARD HYNES, SAMUEL B. FORMAL, AND HUGH COLLINS.. 380 Continued on followingpage Continued from precedingpage Immunology Experimental Cryptococcosis in Normal and B-Cell-Deficient Mice. D. P. MONGA, R. KUMAR,* L. N. MOHAPATRA, AND A. N. MALAVIYA .1 Depression ofContact Sensitivity by Pseudomonas aeruginosa-Induced Suppressor Cells Which Affect the Induction Phase of Immune-Response. C. GARZELLI,* V. COLIZZI, M. CAMPA, L. Bozzi, AND G. FALCONE ........................ 4 Human Neutrophil Migratory Function: Modulatory Effect of Interactions with Opsonized Particles. NEIL E. KAY, STEVEN D. DOUGLAS,* AND ROBERT D. NELSON .............................................................. 12 Elevated Adjuvanticity ofNon-Acid-Fast Mycobacteria. YOSHIKAZu KONDO* AND ToMOHIRo TOIDA ..................................................... 19 Inability of Passively Acquired Antibody to Protect Lambs Against Experimental Pasteurellosis. PETER W. WELLS, HELEN B. EVANS,* CHARLES BURRELLS, JAMES M. SHARP, NEIL J. L. GILMOUR, DENNIS A. THOMPSON, AND BERNARD RUSHTON ............................................................. 25 Reduction of Contact Sensitivity Reactions to Oxazolone in Mite-Infested Mice. HANS LALTOO AND LEON S. KIND* .... 30 Large-Scale Production and Physicochemical Characterization of Human Immune Interferon. M. P. LANGFORD, J. A. GEORGIADES, G. J. STANTON, F. DIANZANI, AND H. M. JOHNSON* .................................................. 36 Radioimmunoassay for Gram-Negative Bacterial Lipopolysaccharide 0 Antigens: Influence of Antigen Solubility. ROBERT S. MUNFORD* AND CATHERINE L. HALL ................................................................. 42 Depression of Vaccinal Immunity to Marek's Disease by Infection with Reticulo- endotheliosis Virus. RICHARD L. WITTER,* Lucy F. LEE, LARRY D. BACON, AND EUGENE J. SMITH ........ 90 Requirements for Immunoglobulin and the Classical and Alternative Complement Pathways for Phagocytosis and Intracellular Killing of Multiple Strains of Gram-Negative Aerobic Bacilli. PHYLLIS LEIST-WELSH AND ANN B. BJORN- SON * 99 Protection Against Group B Meningococcal Disease: Evaluation of Serotype 2 Protein Vaccines in a Mouse Bacteremia Model. DONALD E. CRAVEN* AND CARL E. FRASCH ........................ ............................... 110 Passage of Pseudomonas aeruginosa in Compromised Mice. CHARLES D. Cox 118 Gamma-Irradiated Scrub Typhus Immunogens: Broad-Spectrum Immunity with Combinations of Rickettsial Strains. GEORGE H. G. EISENBERG, JR., AND JOSEPH V. OSTERMAN* ................................................. 131 Influence of Lipopolysaccharide on Graft Versus Host Reactivity of Lipopolysac- charide-Unresponsive C3H/HeJ Mice. PATRICIA A. RAMPY* AND JOHN W. JUTILA .................................... 137 Analysis of the Adhesion Step in the Herpes Simplex Virus Antibody-Dependent Cellular Cytotoxicity System. THOMAS J. ROMANO AND STEVEN L. SHORE* 163 Complement Activation in Acne Vulgaris: Consumption of Complement by Come- dones. GUY F. WEBSTER,* JAMES J. LEYDEN, AND ULF R. NILSSON ....... 183 Thymosin Restoration of Cellular Immunity to Blastomyces dermatitidis T-Cell- Depleted Mice. Ross E. LONGLEY AND GEORGE C. COZAD* .... ........... 187 Role of Environment in the Development of "Natural" Hemagglutinins in Minne- sota Miniature Swine. JAMES W. SCHEFFEL AND YOON BERM KIM* ... 202 Immunogenicity of Soluble Versus Cellular Glycerol Teichoic Acid. FRANK
Recommended publications
  • The Capsule of Porphyromonas Gingivalis Reduces the Immune Response of Human Gingival Fibroblasts
    UvA-DARE (Digital Academic Repository) The capsule of Porphyromonas gingivalis reduces the immune response of human gingival fibroblasts Brunner, J.; Scheres, N.; El Idrissi, N.B.; Deng, D.M.; Laine, M.L.; van Winkelhoff, A.J.; Crielaard, W. DOI 10.1186/1471-2180-10-5 Publication date 2010 Document Version Final published version Published in BMC Microbiology License CC BY Link to publication Citation for published version (APA): Brunner, J., Scheres, N., El Idrissi, N. B., Deng, D. M., Laine, M. L., van Winkelhoff, A. J., & Crielaard, W. (2010). The capsule of Porphyromonas gingivalis reduces the immune response of human gingival fibroblasts. BMC Microbiology, 10, [5]. https://doi.org/10.1186/1471-2180-10-5 General rights It is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), other than for strictly personal, individual use, unless the work is under an open content license (like Creative Commons). Disclaimer/Complaints regulations If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Ask the Library: https://uba.uva.nl/en/contact, or a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You will be contacted as soon as possible. UvA-DARE is a service provided by the library of the University of Amsterdam (https://dare.uva.nl) Download date:29 Sep 2021 Brunner et al.
    [Show full text]
  • Arsinothricin, an Arsenic-Containing Non-Proteinogenic Amino Acid Analog of Glutamate, Is a Broad-Spectrum Antibiotic
    ARTICLE https://doi.org/10.1038/s42003-019-0365-y OPEN Arsinothricin, an arsenic-containing non-proteinogenic amino acid analog of glutamate, is a broad-spectrum antibiotic Venkadesh Sarkarai Nadar1,7, Jian Chen1,7, Dharmendra S. Dheeman 1,6,7, Adriana Emilce Galván1,2, 1234567890():,; Kunie Yoshinaga-Sakurai1, Palani Kandavelu3, Banumathi Sankaran4, Masato Kuramata5, Satoru Ishikawa5, Barry P. Rosen1 & Masafumi Yoshinaga1 The emergence and spread of antimicrobial resistance highlights the urgent need for new antibiotics. Organoarsenicals have been used as antimicrobials since Paul Ehrlich’s salvarsan. Recently a soil bacterium was shown to produce the organoarsenical arsinothricin. We demonstrate that arsinothricin, a non-proteinogenic analog of glutamate that inhibits gluta- mine synthetase, is an effective broad-spectrum antibiotic against both Gram-positive and Gram-negative bacteria, suggesting that bacteria have evolved the ability to utilize the per- vasive environmental toxic metalloid arsenic to produce a potent antimicrobial. With every new antibiotic, resistance inevitably arises. The arsN1 gene, widely distributed in bacterial arsenic resistance (ars) operons, selectively confers resistance to arsinothricin by acetylation of the α-amino group. Crystal structures of ArsN1 N-acetyltransferase, with or without arsinothricin, shed light on the mechanism of its substrate selectivity. These findings have the potential for development of a new class of organoarsenical antimicrobials and ArsN1 inhibitors. 1 Department of Cellular Biology and Pharmacology, Florida International University, Herbert Wertheim College of Medicine, Miami, FL 33199, USA. 2 Planta Piloto de Procesos Industriales Microbiológicos (PROIMI-CONICET), Tucumán T4001MVB, Argentina. 3 SER-CAT and Department of Biochemistry and Molecular Biology, University of Georgia, Athens, GA 30602, USA.
    [Show full text]
  • Contents • May/June 2018 • Volume 9, No. 3
    CONTENTS • MAY/JUNE 2018 • VOLUME 9, NO. 3 FEATURED IMAGE Featured image: Adult female deep-sea anglerfish specimens of Melanocetus johnsonii (top) and Cryptopsaras couesii (bottom), collected on DEEPEND Consortium cruises in the Gulf of Mexico. The lure, which holds luminous bacterial symbionts, is present above each individual’s head. (Photo credit: Danté Fenolio, San Antonio Zoo.) [See related article: Hendry et al., mBio 9(3): e01033-18, 2018.] © 2018 Hendry et al. CC-BY 4.0. LETTERS TO THE EDITOR Multiple Selected Changes May Modulate the Molecular Interaction between e00476-18 Laverania RH5 and Primate Basigin Diego Forni, Chiara Pontremoli, Rachele Cagliani, Uberto Pozzoli, Mario Clerici, Manuela Sironi Inability to Culture Pneumocystis jirovecii e00939-18 Yueqin Liu, Gary A. Fahle, Joseph A. Kovacs AUTHOR REPLIES Reply to Forni et al., “Multiple Selected Changes May Modulate the Molecular e00917-18 Interaction between Laverania RH5 and Primate Basigin” Lindsey J. Plenderleith, Weimin Liu, Oscar A. MacLean, Yingying Li, Dorothy E. Loy, Sesh A. Sundararaman, Frederic Bibollet-Ruche, Gerald H. Learn, Beatrice H. Hahn, Paul M. Sharp Reply to Das and Berkhout, “How Polypurine Tract Changes in the HIV-1 RNA e00623-18 Genome Can Cause Resistance against the Integrase Inhibitor Dolutegravir” Isabelle Malet, Frédéric Subra, Clémence Richetta, Charlotte Charpentier, Gilles Collin, Diane Descamps, Vincent Calvez, Anne-Geneviève Marcelin, Olivier Delelis Reply to Liu et al., “Inability To Culture Pneumocystis jirovecii” e01030-18 Verena Schildgen, Oliver Schildgen PERSPECTIVES The Case for an Expanded Concept of Trained Immunity e00570-18 Antonio Cassone Identifying and Overcoming Threats to Reproducibility, Replicability, Robustness, e00525-18 and Generalizability in Microbiome Research Patrick D.
    [Show full text]
  • Chapter 20 the Proteobacteria
    Fig. 20.21 Chapter 20 purple photosynthetic sulfur bacteria The Proteobacteria may have arose from a single photosynthetic ancestor 16S rRNA shows five distinct lineages 12-27-2011 12-28-2011 Class α-proteobacteria Most are oligotrophic (growing at low nutrient level) Fig. 20.11 Genus Rhizobium motile rods often contain poly-β- hydroxybutyrate (PHB) granules become pleomorphic under adverse conditions grow symbiotically as nitrogen- fixing bacteroids (Æ ammonium) within root nodule cells of legumes Genus Agrobacterium Figure 20.12 transform infected plant cells (crown, roots, and stems) into autonomously proliferating tumors Agrobacterium tumefaciens causes crown gall disease by means of tumor-inducing (Ti) plasmid Crown gall (冠癭) of a tomato plant Agrobacterium Ti (tumor inducing) plamid Transfer the T-DNA to plant and lower fungi Can also mobilize other plasmid with to plant cells A vector used for transgenic plant Fig. 29.13 Genus Brucella important human and animal pathogen (zoonosis) Brucellosis- undulant fever 波型熱 A select agent as biocrime ingestion of contaminated food (milk products); inhalation, via skin wound, rare person-to-person Acute form: flu-like symptom; undulant form: undulant fever, arthritis, and testicular inflammation, neurologic symptom may occur; chronic form: chronic fatigue, depression, and arthritis Class β-proteobacteria Nitrogen metabolism Nitrifying bacteria- Nitrification oxidation of ammonium to nitrite, nitrite further oxidized to nitrate Nitrobacter (α-proteobacteria) Nitrosomonas (β-proteobacteria) Nitrosococcus (γ-proteobacteria) Nitrogen Fixation Burkholderia and Ralstonia (β-proteobacteria) both form symbiotic associations with legumes both have nodulation genes (nod) a common genetic origin with rhizobia (α-proteobacteria) obtained through lateral gene transfer Order Burkholderiales Burkholderia cepacia degrades > 100 organic molecules very active in recycling organic material plant and human pathogen (nosocomial pathogen) a particular problem for cystic fibrosis patients B.
    [Show full text]
  • Cell Structure and Function in the Bacteria and Archaea
    4 Chapter Preview and Key Concepts 4.1 1.1 DiversityThe Beginnings among theof Microbiology Bacteria and Archaea 1.1. •The BacteriaThe are discovery classified of microorganismsinto several Cell Structure wasmajor dependent phyla. on observations made with 2. theThe microscope Archaea are currently classified into two 2. •major phyla.The emergence of experimental 4.2 Cellscience Shapes provided and Arrangements a means to test long held and Function beliefs and resolve controversies 3. Many bacterial cells have a rod, spherical, or 3. MicroInquiryspiral shape and1: Experimentation are organized into and a specific Scientificellular c arrangement. Inquiry in the Bacteria 4.31.2 AnMicroorganisms Overview to Bacterialand Disease and Transmission Archaeal 4.Cell • StructureEarly epidemiology studies suggested how diseases could be spread and 4. Bacterial and archaeal cells are organized at be controlled the cellular and molecular levels. 5. • Resistance to a disease can come and Archaea 4.4 External Cell Structures from exposure to and recovery from a mild 5.form Pili allowof (or cells a very to attach similar) to surfacesdisease or other cells. 1.3 The Classical Golden Age of Microbiology 6. Flagella provide motility. Our planet has always been in the “Age of Bacteria,” ever since the first 6. (1854-1914) 7. A glycocalyx protects against desiccation, fossils—bacteria of course—were entombed in rocks more than 3 billion 7. • The germ theory was based on the attaches cells to surfaces, and helps observations that different microorganisms years ago. On any possible, reasonable criterion, bacteria are—and always pathogens evade the immune system. have been—the dominant forms of life on Earth.
    [Show full text]
  • The Influence of Wall Teichoic Acids on Cell Viability and Morphology in Bacillus Subtilis
    The influence of Wall Teichoic Acids on cell viability and morphology in Bacillus subtilis by Jan Wintgens (S2504618) Master research Project I November 2014 Supervision: Marielle van den Esker Prof. Dr. O.P Kuipers 1 2 Abstract Wall teichoic acids (WTA’s) are negatively charged polymers that play an important role in the cell envelope. Among other functions they are influencing cell morphology and autolysin activity. The mechanism of the latter is only shown in Staphylococcus aureus and is poorly understood. We here show the impact on morphology by WTA’s in detail and started investigating the role of WTA’s in lysis in Bacillus subtilis. Lacking the first step in WTA biosynthesis the ΔtagO conditional knockout mutant was used to characterise growth under different wall teichoic acid concentrations. We found that growth is generally impaired and initially cannot be complemented to WT level. The mutant however, surprisingly regrows after a lysis phase of diverging length, a phenomenon that requires further investigation. Measuring the morphology of the mutant, we were able to show in a detailed length to width ratio analysis that WTA are important to maintain the rod shape of the bacteria. We also detected an increase of volume by up to 330% caused by the lack of WTA’s. Both results show that wall teichoic acids are a structure that is partially responsible for cell shape maintenance in gram positive bacteria. A difference in charge or size between WTA in the WT and in the mutant is apparent in our results. It gives insight in the reaction of the cell to a lack of WTA’s and the regulation of their biosynthesis.
    [Show full text]
  • Oral Microbiota: a Major Player in the Diagnosis of Systemic Diseases
    diagnostics Review Oral Microbiota: A Major Player in the Diagnosis of Systemic Diseases Charlotte Thomas 1,2,3,*,†, Matthieu Minty 1,2,3,*,†, Alexia Vinel 1,2,3, Thibault Canceill 2,3,4, Pascale Loubières 1,2, Remy Burcelin 1,2, Myriam Kaddech 2,3, Vincent Blasco-Baque 1,2,3,† and Sara Laurencin-Dalicieux 2,3,5,† 1 INSERM UMR 1297 Inserm, Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), Avenue Jean Poulhès 1, CEDEX 4, 31432 Toulouse, France; [email protected] (A.V.); [email protected] (P.L.); [email protected] (R.B.); [email protected] (V.B.-B.) 2 Faculté de Chirurgie Dentaire, Université Paul Sabatier III (UPS), 118 Route de Narbonne, CEDEX 9, 31062 Toulouse, France; [email protected] (T.C.); [email protected] (M.K.); [email protected] (S.L.-D.) 3 Service d’Odontologie Rangueil, CHU de Toulouse, 3 Chemin des Maraîchers, CEDEX 9, 31062 Toulouse, France 4 UMR CNRS 5085, Centre Interuniversitaire de Recherche et d’Ingénierie des Matériaux (CIRIMAT), Université Paul Sabatier, 35 Chemin des Maraichers, CEDEX 9, 31062 Toulouse, France 5 INSERM UMR 1295, Centre d’Epidémiologie et de Recherche en Santé des Populations de Toulouse (CERPOP), Epidémiologie et Analyse en Santé Publique, Risques, Maladies Chroniques et Handicaps, 37 Allées Jules Guesdes, 31000 Toulouse, France * Correspondence: [email protected] (C.T.); [email protected] (M.M.); Tel.: +33-5-61-32-56-12 (C.T. & M.M.); Fax: +33-5-31-22-41-36 (C.T. & M.M.) † These authors contributed equally to this work.
    [Show full text]
  • Periodontitis As a Risk Factor of Atherosclerosis
    Hindawi Publishing Corporation Journal of Immunology Research Volume 2014, Article ID 636893, 9 pages http://dx.doi.org/10.1155/2014/636893 Review Article Periodontitis as a Risk Factor of Atherosclerosis Jirina Bartova, Pavla Sommerova, Yelena Lyuya-Mi, Jaroslav Mysak, Jarmila Prochazkova, Jana Duskova, Tatjana Janatova, and Stepan Podzimek Institute of Clinical and Experimental Dental Medicine, First Faculty of Medicine and General University Hospital, Charles University, Karlovo Namesti 32, 12000 Prague, Czech Republic Correspondence should be addressed to Stepan Podzimek; [email protected] Received 8 November 2013; Revised 29 January 2014; Accepted 17 February 2014; Published 23 March 2014 Academic Editor: Douglas C. Hooper Copyright © 2014 Jirina Bartova et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Over the last two decades, the amount of evidence corroborating an association between dental plaque bacteria and coronary diseases that develop as a result of atherosclerosis has increased. These findings have brought a new aspect to the etiology of the disease. There are several mechanisms by which dental plaque bacteria may initiate or worsen atherosclerotic processes: activation of innate immunity, bacteremia related to dental treatment, and direct involvement of mediators activated by dental plaque and involvement of cytokines and heat shock proteins from dental plaque bacteria. There are common predisposing factors which influence both periodontitis and atherosclerosis. Both diseases can be initiated in early childhood, although the first symptoms may not appear until adulthood. The formation of lipid stripes has been reported in 10-year-old children and the increased prevalence of obesity in children and adolescents is a risk factor contributing to lipid stripes development.
    [Show full text]
  • Fate of Arsenate Following Arsenite Oxidation in Agrobacterium Tumefaciens GW4
    bs_bs_banner Environmental Microbiology (2014) doi:10.1111/1462-2920.12465 Fate of arsenate following arsenite oxidation in Agrobacterium tumefaciens GW4 Qian Wang,1 Dong Qin,1 Shengzhe Zhang,1 Introduction Lu Wang,1 Jingxin Li,1 Christopher Rensing,2 Arsenic (As) is the most common toxic element in the Timothy R. McDermott3** and Gejiao Wang1* environment, ranking first on the U.S. Superfund List 1State Key Laboratory of Agricultural Microbiology, of Hazardous Substances and is responsible for mass College of Life Science and Technology, Huazhong poisoning throughout Asia (Chakraborti et al., 2009; Agricultural University, Wuhan 430070, China. Rodríguez-Lado et al., 2013). In the environment, trans- 2Department of Plant and Environmental Sciences, port, bioavailability and accumulation of As in biological University of Copenhagen, Frederiksberg, Denmark. endpoints is dependent on chemical speciation, with 3Department of Land Resources and Environmental arsenite (AsIII) and arsenate (AsV) being the primary Sciences, Montana State University, Bozeman, MT arsenicals found in the environment. Microbial redox 59717, USA. transformations are recognized as being important con- tributors to equilibrium levels of AsIII and AsV (Cullen and Summary Reimer, 1989; Inskeep et al., 2001; Oremland and Stolz, 2005; Stolz et al., 2006). The fate of arsenate (AsV) generated by microbial Microbial AsIII oxidation and AsV reduction both serve arsenite (AsIII) oxidation is poorly understood. as detoxification and/or energy-generating functions, Agrobacterium tumefaciens wild-type strain (GW4) depending on the organism (Stolz et al., 2006; Páez- was studied to determine how the cell copes with AsV Espino et al., 2009). Reasonable models exist for under- generated in batch culture.
    [Show full text]
  • Taxonomic Studies of Two Species of Peptococci and Inhibition of Peptostreptococcus Anaerobius by Sodium Polyanethol Sulfonate;
    ,Taxonomic Studies of Two Species of Peptococci and Inhibition of Peptostreptococcus anaerobius by Sodium Polyanethol Sulfonate; by Susan Emily Holt West1, \\ ! Thesis submitted to the Graduate Faculty of the Virginia Polytechnic Institute and State University in partial fulfillment of the requirements for the degree of MASTER OF SCIENCE in Microbiology (Anaerobe Laboratory) APPROVED: •r• /' ., ~ T. £. Wilkins, Chairman _,.-,--------------- L. V. Holdeman E. R. Stout April, 1977 Blacksburg, Virginia ACKNOWLEDGEMENTS Initial thanks are due Tracy D. Wilkins for serving as chairman of my thesis committee. To Lillian V. Holdeman of my committee I am especially grateful, both for her many specific suggestions concerning this thesis, and also for the general training I have recieved from her, and for the attitude toward research that I believe I have learned from her. Ernest R. Stout, also a member of the committee, has fulfilled his duties conscientiously and has provided much encouragement and support. I owe special thanks to , who initially stimulated my interest in bacteriology many years ago, and who has continued to show interest in the progress of my career. Several other scientists have been helpful: of the Anaerobe Laboratory determined the percent guanine plus cytosine content of the deoxyribonucleic acid of the type strain of Peptococcus niger; of the Becton-Dickinson Company first suggested the direction of our research on sodium polyanethol sulfonate inhibition of anaerobic cocci; and of the Institut fur Klinische Mikrobiologie und Infektionshygiene der Universitat Erlangen-NUrnberg, West Germany, very kindly sent cultures of Escherichia coli C and Serratia marcescens SM 29. of the Department ·of Foreign Languages, VPI & SU, provided translations of the German texts of several papers that were significant in the Peptococcus anaerobius project.
    [Show full text]
  • Proton-Binding Capacity of Staphylococcus Aureus Wall Teichoic Acid and Its Role in Controlling Autolysin Activity
    Proton-Binding Capacity of Staphylococcus aureus Wall Teichoic Acid and Its Role in Controlling Autolysin Activity Raja Biswas1, Raul E. Martinez2, Nadine Go¨ hring1, Martin Schlag3, Michaele Josten4, Guoqing Xia1, Florian Hegler2, Cordula Gekeler1, Anne-Kathrin Gleske1, Friedrich Go¨ tz3, Hans-Georg Sahl4, Andreas Kappler2, Andreas Peschel1* 1 Interfaculty Institute of Microbiology and Infection Medicine, Cellular and Molecular Microbiology, University of Tu¨bingen, Tu¨bingen, Germany, 2 Center for Applied Geoscience, Geomicrobiology, University of Tu¨bingen, Tu¨bingen, Germany, 3 Interfaculty Institute of Microbiology and Infection Medicine, Microbial Genetics, University of Tu¨bingen, Tu¨bingen, Germany, 4 Institute for Medical Microbiology, Immunology and Parasitology (IMMIP), Pharmaceutical Microbiology Unit, University of Bonn, Bonn, Germany Abstract Wall teichoic acid (WTA) or related polyanionic cell wall glycopolymers are produced by most Gram-positive bacterial species and have been implicated in various cellular functions. WTA and the proton gradient across bacterial membranes are known to control the activity of autolysins but the molecular details of these interactions are poorly understood. We demonstrate that WTA contributes substantially to the proton-binding capacity of Staphylococcus aureus cell walls and controls autolysis largely via the major autolysin AtlA whose activity is known to decline at acidic pH values. Compounds that increase or decrease the activity of the respiratory chain, a main source of protons in the cell wall, modulated autolysis rates in WTA-producing cells but did not affect the augmented autolytic activity observed in a WTA-deficient mutant. We propose that WTA represents a cation-exchanger like mesh in the Gram-positive cell envelopes that is required for creating a locally acidified milieu to govern the pH-dependent activity of autolysins.
    [Show full text]
  • The Potential of Human Peptide LL-37 As an Antimicrobial and Anti-Biofilm Agent
    antibiotics Review The Potential of Human Peptide LL-37 as an Antimicrobial and Anti-Biofilm Agent Kylen E. Ridyard and Joerg Overhage * Department of Health Sciences, Carleton University, Ottawa, ON K1S 5B6, Canada; [email protected] * Correspondence: [email protected]; Tel.: +1-613-520-2600 Abstract: The rise in antimicrobial resistant bacteria threatens the current methods utilized to treat bacterial infections. The development of novel therapeutic agents is crucial in avoiding a post- antibiotic era and the associated deaths from antibiotic resistant pathogens. The human antimicrobial peptide LL-37 has been considered as a potential alternative to conventional antibiotics as it displays broad spectrum antibacterial and anti-biofilm activities as well as immunomodulatory functions. While LL-37 has shown promising results, it has yet to receive regulatory approval as a peptide antibiotic. Despite the strong antimicrobial properties, LL-37 has several limitations including high cost, lower activity in physiological environments, susceptibility to proteolytic degradation, and high toxicity to human cells. This review will discuss the challenges associated with making LL-37 into a viable antibiotic treatment option, with a focus on antimicrobial resistance and cross-resistance as well as adaptive responses to sub-inhibitory concentrations of the peptide. The possible methods to overcome these challenges, including immobilization techniques, LL-37 delivery systems, the development of LL-37 derivatives, and synergistic combinations will also be considered. Herein, we Citation: Ridyard, K.E.; Overhage, J. describe how combination therapy and structural modifications to the sequence, helicity, hydropho- The Potential of Human Peptide bicity, charge, and configuration of LL-37 could optimize the antimicrobial and anti-biofilm activities LL-37 as an Antimicrobial and of LL-37 for future clinical use.
    [Show full text]